SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000062391-97-000008
Filing Date
1997-01-10
Accepted
1997-01-10 00:00:00
Documents
4
Group Members
HMR PHARMA, INC.HOECHST MARION ROUSSEL INC
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 HMRI/HMR PHARMA AMEND #2 TO LYNX 13D SC 13D/A 16058
2 EXHIBIT 99D TO LYNX 13D EX-99 1013
3 EXHIBIT 99E TO LYNX 13D EX-99 3720
4 EXHIBIT 99F TO LYNX 13D EX-99 5071
  Complete submission text file 0000062391-97-000008.txt   28496
Mailing Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627
Business Address 10236 MARION PARK DRIVE P O BOX 9627 KANSAS CITY MO 64134-0627 8169665000
HOECHST MARION ROUSSEL INC (Filed by) CIK: 0000062391 (see all company filings)

IRS No.: 440565557 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 74545
Business Address 3832 BAY CENTER PLACE HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45671 | Film No.: 97504063
SIC: 2833 Medicinal Chemicals & Botanical Products